Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 28;221(8):1315-1320.
doi: 10.1093/infdis/jiz184.

Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency Virus

Affiliations

Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency Virus

Markella V Zanni et al. J Infect Dis. .

Abstract

Human immunodeficiency virus (HIV) imparts increased heart failure risk to women. Among women with HIV (WHIV), immune pathways relating to heart failure precursors may intimate targets for heart failure prevention strategies. Twenty asymptomatic, antiretroviral-treated WHIV and 14 non-HIV-infected women matched on age and body mass index underwent cardiac magnetic resonance imaging and immune phenotyping. WHIV (vs non-HIV-infected women) exhibited increased myocardial fibrosis (extracellular volume fraction, 0.34 ± 0.06 vs 0.29 ± 0.04; P = .002), reduced diastolic function (diastolic strain rate, 1.10 ± 0.23 s-1 vs 1.39 ± 0.27 s-1; P = .003), and heightened systemic monocyte activation. Among WHIV, soluble CD163 levels correlated with myocardial fibrosis (r = 0.53; P = .02), while circulating inflammatory CD14+CD16+ monocyte CCR2 expression related directly to myocardial fibrosis (r = 0.48; P = .04) and inversely to diastolic function (r = -0.49; P = .03). Clinical Trials Registration. NCT02874703.

Keywords: HIV; diastolic dysfunction; inflammation; myocardial fibrosis; women.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Diffuse myocardial fibrosis and diastolic function among women with human immunodeficiency virus (WHIV) and women without human immunodeficiency virus (HIV). A, Diffuse myocardial fibrosis, as quantified by the cardiac magnetic resonance imaging (MRI) measure of extracellular volume fraction, was increased among WHIV (n = 19; extracellular volume fraction uninterpretable for 1 participant) compared with non-HIV-infected women (n = 14) (P = .002 by t test). B, Diastolic function, as quantified by the cardiac MRI measure of circumferential diastolic strain rate, was reduced among WHIV (n = 20) compared with non-HIV-infected women (n = 14) (P = .003 by t test). In both graphs, data are presented as box plots, where the box represents the median and interquartile range and the whiskers represent the minimum and maximum values.

Comment in

References

    1. Janjua SA, Triant VA, Addison D, et al. . HIV infection and heart failure outcomes in women. J Am Coll Cardiol 2017; 69:107–8. - PMC - PubMed
    1. Womack JA, Chang CC, So-Armah KA, et al. . HIV infection and cardiovascular disease in women. J Am Heart Assoc 2014; 3:e001035. - PMC - PubMed
    1. Freiberg MS, Chang CH, Skanderson M, et al. . Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from the Veterans Aging Cohort Study. JAMA Cardiol 2017; 2:536–46. - PMC - PubMed
    1. Holloway CJ, Ntusi N, Suttie J, et al. . Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation 2013; 128:814–22. - PubMed
    1. Nelson MD, Szczepaniak LS, LaBounty TM, et al. . Cardiac steatosis and left ventricular dysfunction in HIV-infected patients treated with highly active antiretroviral therapy. JACC Cardiovasc Imaging 2014; 7:1175–7. - PMC - PubMed

Publication types

MeSH terms

Substances

Associated data